We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Oruba Showcases Innovative Self-Operating Uroflowmeter

By LabMedica International staff writers
Posted on 12 Nov 2024

Oruba Technology & Innovation (Langenfeld, Germany) is showcasing its innovative self-operating uroflowmeter, Oruflow, including both the urinal and toilet versions, at MEDICA 2024. More...

Oruflow is the world’s first self-operating uroflowmeter. As a point-of-care (POC) diagnostic device, it eases and accelerates the uroflowmetry process in a hygienic and comfortable atmosphere, making it a crucial part of every hospital and urology clinic. Oruba Oruflow is available in two versions for urology clinics – the Oruflow i POC diagnostic urinal and the Oruflow h POC diagnostic toilet. Both the devices feature an on-board screen to assist patients before and after examinations. The patient can receive the results of the examination in seconds without any operator guidance. The patient uses the hospital barcode to let Oruba Oruflow save the examination report into the hospital information system automatically.

The Oruflow h features a specially designed adapter enabling accurate and comfortable uroflowmetry testing for individuals of all gender types and ages. This ergonomic adapter is designed to accommodate anatomical differences such as the urination posture of women, ensuring a seamless and user-friendly experience. This adaptor is also suitable for children, providing the same level of comfort and accuracy. Oruflow h introduces a groundbreaking feature: The anatomical design of the toilet which separates stool and urine. With this feature, Oruflow h continues working even after accidental defecation, ensuring reliable performance in all conditions.

Both the Oruflow models have an EMG (electromyography) option, which provides synchronized uroflowmetry and EMG measurements. While the Oruflow measures the urine flow rate, the EMG module measures the electrical activity of the muscles before, during, and after urination to evaluate urinary problems. In biofeedback, EMG results are displayed using a bird game interface which is also virtual reality-compatible. When the patient contracts their muscles, the bird flaps. The doctor can change the scale and see the results synchronously.

Related Links:
Oruba Technology & Innovation


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Electrolyte Analyzer
BKE-B
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.